bg_image
Dr. SAMER ALZOUBI

Dr. SAMER ALZOUBI

Researcher and university professor specializing in Genetic Engineering and Molecular Medicine, holding a Ph.D. from Imperial College London in the UK, a Master’s degree in Molecular Medicine from Queen’s University Belfast, in addition to a Diploma in Animal Sciences and a Bachelor's degree in Natural Sciences from the University of Damascus.

He possesses extensive university teaching experience spanning over ten years at the University of Damascus and the Arab International University, where he taught courses in Genetics, Cellular and Molecular Biology, Embryology, Biotechnology, Epidemiology, and Animal Biology. He has held several administrative positions, most notably: Head of the Cytogenetics Laboratory at the Biotherapeutics Research Laboratory at the University of Damascus, Vice Dean for Academic Affairs at the Faculty of Health Sciences, and Assistant General Supervisor of the Preparatory Year.

He has published scientific research in internationally peer-reviewed journals, including a study in Oncotarget on "The relationship between histone deacetylase inhibitors and DNA-damaging factors in colorectal cancer." He also contributed to editing the fourth edition of the book Introduction to Biotechnology, published by Pearson in 2020.

His research expertise focuses on genetic engineering modifications, molecular biology techniques, studying drug resistance in cancer, and DNA and protein data analysis, with practical experience in handling laboratory animals according to British standards.

He has participated in numerous national scientific conferences and has delivered several lectures in the fields of genetic diseases, biotechnology, and the health applications of Omics sciences.

Experience
Researcher and university professor specializing in Genetic Engineering and Molecular Medicine, holding a Ph.D. from Imperial College London in the UK, a Master’s degree in Molecular Medicine from Queen’s University Belfast, in addition to a Diploma in Animal Sciences and a Bachelor's degree in Natural Sciences from the University of Damascus.

He possesses extensive university teaching experience spanning over ten years at the University of Damascus and the Arab International University, where he taught courses in Genetics, Cellular and Molecular Biology, Embryology, Biotechnology, Epidemiology, and Animal Biology. He has held several administrative positions, most notably: Head of the Cytogenetics Laboratory at the Biotherapeutics Research Laboratory at the University of Damascus, Vice Dean for Academic Affairs at the Faculty of Health Sciences, and Assistant General Supervisor of the Preparatory Year.

He has published scientific research in internationally peer-reviewed journals, including a study in Oncotarget on "The relationship between histone deacetylase inhibitors and DNA-damaging factors in colorectal cancer." He also contributed to editing the fourth edition of the book Introduction to Biotechnology, published by Pearson in 2020.

His research expertise focuses on genetic engineering modifications, molecular biology techniques, studying drug resistance in cancer, and DNA and protein data analysis, with practical experience in handling laboratory animals according to British standards.

He has participated in numerous national scientific conferences and has delivered several lectures in the fields of genetic diseases, biotechnology, and the health applications of Omics sciences.

Education

Ph.D. in Genetic Engineering, Department of Experimental Medicine, Imperial College London, Britain 2013.
MSc in Molecular Medicine, Queen’s University, Belfast, Northern Ireland, Britain 2009.
Educational Habilitation Diploma, Faculty of Education, Damascus University, Syria 2003.
Higher Diploma in Animal Life Sciences, Department of Biology, Faculty of Sciences, Damascus University, Syria 2001.
BSc degree in Biology, Department of Biology, Faculty of Sciences, Damascus University, Syria 2000.

Publication
Alzoubi S., Brody L., Rahman S., Mahul-Mellier A., Mercado N., Ito K., El-Bahrawy M., Silver A., Boobis A., Bell J. D., Hajji N. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget. 2016; 7: 44505-44521
Help